Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

High diagnostic yield and novel variants in very late-onset spasticity.

Almomen M, Martens K, Quadir A, Pontifex CS, Hanson A, Korngut L, Pfeffer G.

J Neurogenet. 2019 Mar;33(1):27-32. doi: 10.1080/01677063.2019.1566326. Epub 2019 Feb 12.

PMID:
30747022
2.

"If it helps someone, then I want to do it": Perspectives of persons living with dementia on research registry participation.

Lee JY, Crooks RE, Pham T, Korngut L, Patten S, Jetté N, Smith EE, Roach P.

Dementia (London). 2019 Feb 5:1471301219827709. doi: 10.1177/1471301219827709. [Epub ahead of print]

PMID:
30722693
3.

Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis.

Hodgkinson VL, Lounsberry J, Mirian A, Genge A, Benstead T, Briemberg H, Grant I, Hader W, Johnston WS, Kalra S, Linassi G, Massie R, Melanson M, O'Connell C, Schellenberg K, Shoesmith C, Taylor S, Worley S, Zinman L, Korngut L.

Can J Neurol Sci. 2018 Nov;45(6):652-659. doi: 10.1017/cjn.2018.311.

PMID:
30430962
4.

Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease.

Wood L, Bassez G, Bleyenheuft C, Campbell C, Cossette L, Jimenez-Moreno AC, Dai Y, Dawkins H, Manera JAD, Dogan C, El Sherif R, Fossati B, Graham C, Hilbert J, Kastreva K, Kimura E, Korngut L, Kostera-Pruszczyk A, Lindberg C, Lindvall B, Luebbe E, Lusakowska A, Mazanec R, Meola G, Orlando L, Takahashi MP, Peric S, Puymirat J, Rakocevic-Stojanovic V, Rodrigues M, Roxburgh R, Schoser B, Segovia S, Shatillo A, Thiele S, Tournev I, van Engelen B, Vohanka S, Lochmüller H.

Orphanet J Rare Dis. 2018 Sep 5;13(1):155. doi: 10.1186/s13023-018-0889-0.

5.

Response to the Canadian Agency for Drugs and Technologies in Health and Institut national d'excellence en santé et en services sociaux decision regarding nusinersen for Spinal Muscular Atrophy.

Campbell C, Selby K, McMillan H, Vajsar J, Korngut L, Brais B, MacKenzie A, Oskoui M.

Can J Neurol Sci. 2018 Sep;45(5):516-517. doi: 10.1017/cjn.2018.59. Epub 2018 Jul 24. No abstract available.

PMID:
30039778
6.

The Canadian Neuromuscular Disease Registry: Connecting patients to national and international research opportunities.

Wei Y, McCormick A, MacKenzie A, O'Ferrall E, Venance S, Mah JK, Selby K, McMillan HJ, Smith G, Oskoui M, Hogan G, McAdam L, Mabaya G, Hodgkinson V, Lounsberry J, Korngut L, Campbell C.

Paediatr Child Health. 2018 Feb;23(1):20-26. doi: 10.1093/pch/pxx125. Epub 2017 Dec 8.

7.

The Utility of the Laboratory Work Up at the Time of Diagnosis of Amyotrophic Lateral Sclerosis.

Mirian A, Korngut L.

J Neuromuscul Dis. 2018;5(1):35-38. doi: 10.3233/JND-170281.

PMID:
29278899
8.

Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys.

Potter BK, Hutton B, Clifford TJ, Pallone N, Smith M, Stockler S, Chakraborty P, Barbeau P, Garritty CM, Pugliese M, Rahman A, Skidmore B, Tessier L, Tingley K, Coyle D, Greenberg CR, Korngut L, MacKenzie A, Mitchell JJ, Nicholls S, Offringa M, Schulze A, Taljaard M; Canadian Inherited Metabolic Diseases Research Network.

Trials. 2017 Dec 19;18(1):603. doi: 10.1186/s13063-017-2327-3. Review.

9.

Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis.

Patten SA, Aggad D, Martinez J, Tremblay E, Petrillo J, Armstrong GA, La Fontaine A, Maios C, Liao M, Ciura S, Wen XY, Rafuse V, Ichida J, Zinman L, Julien JP, Kabashi E, Robitaille R, Korngut L, Parker JA, Drapeau P.

JCI Insight. 2017 Nov 16;2(22). pii: 97152. doi: 10.1172/jci.insight.97152. eCollection 2017 Nov 16.

10.

Decremental responses in patients with motor neuron disease.

Alanazy MH, Hegedus J, White C, Korngut L.

Brain Behav. 2017 Sep 26;7(11):e00846. doi: 10.1002/brb3.846. eCollection 2017 Nov.

11.

Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database.

Koeks Z, Bladen CL, Salgado D, van Zwet E, Pogoryelova O, McMacken G, Monges S, Foncuberta ME, Kekou K, Kosma K, Dawkins H, Lamont L, Bellgard MI, Roy AJ, Chamova T, Guergueltcheva V, Chan S, Korngut L, Campbell C, Dai Y, Wang J, Barišić N, Brabec P, Lähdetie J, Walter MC, Schreiber-Katz O, Karcagi V, Garami M, Herczegfalvi A, Viswanathan V, Bayat F, Buccella F, Ferlini A, Kimura E, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Kostera-Pruszczyk A, Santos R, Neagu E, Artemieva S, Rasic VM, Vojinovic D, Posada M, Bloetzer C, Klein A, Díaz-Manera J, Gallardo E, Karaduman AA, Oznur T, Topaloğlu H, El Sherif R, Stringer A, Shatillo AV, Martin AS, Peay HL, Kirschner J, Flanigan KM, Straub V, Bushby K, Béroud C, Verschuuren JJ, Lochmüller H.

J Neuromuscul Dis. 2017;4(4):293-306. doi: 10.3233/JND-170280.

12.

Obinutuzumab Plus Chlorambucil in a Patient with Severe Myasthenia Gravis and Chronic Lymphocytic Leukemia.

Russell A, Yaraskavitch M, Fok D, Chhibber S, Street L, Korngut L.

J Neuromuscul Dis. 2017;4(3):251-257. doi: 10.3233/JND-170211.

PMID:
28869483
13.

Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research?

Li G, Sajobi TT, Menon BK, Korngut L, Lowerison M, James M, Wilton SB, Williamson T, Gill S, Drogos LL, Smith EE, Vohra S, Hill MD, Thabane L; 2016 Symposium on Registry-Based Randomized Controlled Trials in Calgary.

J Clin Epidemiol. 2016 Dec;80:16-24. doi: 10.1016/j.jclinepi.2016.08.003. Epub 2016 Aug 20. Review.

PMID:
27555082
14.

Physician-assisted death: A Canada-wide survey of ALS health care providers.

Abrahao A, Downar J, Pinto H, Dupré N, Izenberg A, Kingston W, Korngut L, O'Connell C, Petrescu N, Shoesmith C, Tandon A, Vargas-Santos AB, Zinman L.

Neurology. 2016 Sep 13;87(11):1152-60. doi: 10.1212/WNL.0000000000002786. Epub 2016 May 13.

15.

Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel.

Tarnopolsky M, Katzberg H, Petrof BJ, Sirrs S, Sarnat HB, Myers K, Dupré N, Dodig D, Genge A, Venance SL, Korngut L, Raiman J, Khan A.

Can J Neurol Sci. 2016 Jul;43(4):472-85. doi: 10.1017/cjn.2016.37. Epub 2016 Apr 8. Review.

PMID:
27055517
16.

A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies.

Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, Jette N.

Can J Neurol Sci. 2016 Jan;43(1):163-77. doi: 10.1017/cjn.2015.311. Review.

PMID:
26786644
17.

The promise of futility trials in neurological diseases.

Koch MW, Korngut L, Patry DG, Agha-Khani Y, White C, Sarna JR, Yeung M, Yong VW, Heng DY, Cutter G, Metz L.

Nat Rev Neurol. 2015 May;11(5):300-5. doi: 10.1038/nrneurol.2015.34. Epub 2015 Mar 17. Review.

PMID:
25776824
18.

The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.

Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, Dawkins H, Lamont L, Roy AJ, Chamova T, Guergueltcheva V, Chan S, Korngut L, Campbell C, Dai Y, Wang J, Barišić N, Brabec P, Lahdetie J, Walter MC, Schreiber-Katz O, Karcagi V, Garami M, Viswanathan V, Bayat F, Buccella F, Kimura E, Koeks Z, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Kostera-Pruszczyk A, Zimowski J, Santos R, Neagu E, Artemieva S, Rasic VM, Vojinovic D, Posada M, Bloetzer C, Jeannet PY, Joncourt F, Díaz-Manera J, Gallardo E, Karaduman AA, Topaloğlu H, El Sherif R, Stringer A, Shatillo AV, Martin AS, Peay HL, Bellgard MI, Kirschner J, Flanigan KM, Straub V, Bushby K, Verschuuren J, Aartsma-Rus A, Béroud C, Lochmüller H.

Hum Mutat. 2015 Apr;36(4):395-402. doi: 10.1002/humu.22758. Epub 2015 Mar 17.

19.

The Search for Pompe Patients in Canada: Assessing Feasibility of a National Disease Registry to Facilitate Research.

Korngut L, Johnston M, Campbell C, Genge A, MacKenzie A, McCormick A, Venance S.

J Neuromuscul Dis. 2015;2(s1):S45-S46. No abstract available.

PMID:
27858639
20.

Limitations of split-night polysomnography for the diagnosis of nocturnal hypoventilation and titration of non-invasive positive pressure ventilation in amyotrophic lateral sclerosis.

Loewen AH, Korngut L, Rimmer K, Damji O, Turin TC, Hanly PJ.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):494-8. doi: 10.3109/21678421.2014.942866. Epub 2014 Aug 11.

PMID:
25109404
21.

Use of the interRAI CHESS scale to predict mortality among persons with neurological conditions in three care settings.

Hirdes JP, Poss JW, Mitchell L, Korngut L, Heckman G.

PLoS One. 2014 Jun 10;9(6):e99066. doi: 10.1371/journal.pone.0099066. eCollection 2014.

22.

Diagnostic yield and cost-effectiveness of investigations in patients presenting with isolated lower motor neuron signs.

Alanazy MH, White C, Korngut L.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):414-9. doi: 10.3109/21678421.2014.913635. Epub 2014 May 27.

PMID:
24863134
23.

A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy.

Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N.

Neuromuscul Disord. 2014 Jun;24(6):482-91. doi: 10.1016/j.nmd.2014.03.008. Epub 2014 Mar 22. Review.

PMID:
24780148
24.

Reevaluating the risk of DVT in people with ALS: weak in the knees and DVTs.

Berry JD, Korngut L.

Neurology. 2014 May 13;82(19):1668-9. doi: 10.1212/WNL.0000000000000420. Epub 2014 Apr 11. No abstract available.

PMID:
24727310
25.

Profile of patients with amyotrophic lateral sclerosis across continuum of care.

Kehyayan V, Korngut L, Jetté N, Hirdes JP.

Can J Neurol Sci. 2014 Mar;41(2):246-52.

PMID:
24534038
26.

Perspectives on neurological patient registries: a literature review and focus group study.

Korngut L, MacKean G, Casselman L, Johnston M, Day L, Lam D, Lorenzetti D, Warner J, Jetté N, Pringsheim T.

BMC Med Res Methodol. 2013 Nov 9;13:135. doi: 10.1186/1471-2288-13-135. Review.

27.

Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe.

Bladen CL, Thompson R, Jackson JM, Garland C, Wegel C, Ambrosini A, Pisano P, Walter MC, Schreiber O, Lusakowska A, Jedrzejowska M, Kostera-Pruszczyk A, van der Pol L, Wadman RI, Gredal O, Karaduman A, Topaloglu H, Yilmaz O, Matyushenko V, Rasic VM, Kosac A, Karcagi V, Garami M, Herczegfalvi A, Monges S, Moresco A, Chertkoff L, Chamova T, Guergueltcheva V, Butoianu N, Craiu D, Korngut L, Campbell C, Haberlova J, Strenkova J, Alejandro M, Jimenez A, Ortiz GG, Enriquez GV, Rodrigues M, Roxburgh R, Dawkins H, Youngs L, Lahdetie J, Angelkova N, Saugier-Veber P, Cuisset JM, Bloetzer C, Jeannet PY, Klein A, Nascimento A, Tizzano E, Salgado D, Mercuri E, Sejersen T, Kirschner J, Rafferty K, Straub V, Bushby K, Verschuuren J, Beroud C, Lochmüller H.

J Neurol. 2014 Jan;261(1):152-63. doi: 10.1007/s00415-013-7154-1. Epub 2013 Oct 27.

PMID:
24162038
28.

Common data elements for neurological registries.

Warner J, Johnston M, Korngut L, Jette N, Pringsheim T.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S62-3. Review. No abstract available.

PMID:
23787272
29.

Evaluation of neurological patient registries.

Mah JK, Warner J, Hall R, Smith EE, Steeves T, Donner E, Marriott J, Johnston M, Lowerison M, de Robles P, Noonan VK, Mehina E, Jette N, Pringsheim T, Korngut L.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S60-1. Review. No abstract available.

PMID:
23787271
30.

Neurological registry feasibility and sustainability.

Pringsheim T, Marrie RA, Donner E, Shevell M, Lam D, Day L, Johnston M, Jette N, Korngut L.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S55-9. No abstract available.

PMID:
23787270
31.

Validation and interpretation of neurological registry data.

Pringsheim T, Lam D, Day L, Genge A, Hogan DB, Shevell M, Fortin CM, Maxwell C, Fiebelkorn G, Barlow K, Kapral MK, Casha S, Mobach T, Johnston M, Jette N, Korngut L.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S51-3. Review. No abstract available.

PMID:
23787269
32.

Ethical and legal considerations for Canadian registries.

Hogan DB, Warner J, Patten S, Godlovitch G, Mehina E, Dagenais L, Fiebelkorn G, de Robles P, Mackean G, Casselman L, Jette N, Pringsheim T, Korngut L, Johnston M.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S5-22. Review. No abstract available.

PMID:
23787268
33.

Neurological registry quality control and quality assurance.

Marriott J, Noonan VK, Donner E, Lowerison M, Lam D, Day L, Warner J, Smith EE, Mah JK, de Robles P, Jette N, Johnston M, Pringsheim T, Korngut L.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S47-50. Review. No abstract available.

PMID:
23787267
34.

Online neurological registries.

Johnston M, Campbell C, Godlovitch G, Day L, Wysocki J, Dagenais L, Jette N, Korngut L, Pringsheim T, Marrie RA.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S41-5. Review. No abstract available.

PMID:
23787266
35.

Registry data storage and curation.

Johnston M, Campbell C, Hayward R, Lowerison M, Noonan VK, Pfister T, Maxwell C, Fortin CM, Smith EE, Mah JK, Kapral MK, Jette N, Pringsheim T, Korngut L.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S35-40. Review. No abstract available.

PMID:
23787265
36.

Linkage between neurological registry data and administrative data.

Jette N, Atwood K, Hamilton M, Hayward R, Day L, Mobach T, Maxwell C, Fortin CM, Fiebelkorn G, Barlow K, Shevell M, Kapral MK, Casha S, Johnston M, Wiebe S, Korngut L, Pringsheim T.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S32-4. Review. No abstract available.

PMID:
23787264
37.

Neurological registry data collection methods and configuration.

Smith EE, Warner J, Johnston M, Atwood K, Hall R, Mah JK, Maxwell C, Fortin CM, Lowerison M, Kapral MK, Noonan VK, Pfister T, Mackean G, Casselman L, Pringsheim T, Jette N, Korngut L.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S27-31. Review. No abstract available.

PMID:
23787263
38.

Patient recruitment by neurological registries.

Hamilton M, Genge A, Johnston M, Lam D, Mobach T, Marriott J, Steeves T, Donner E, Wysocki J, Barlow K, Shevell M, Marrie RA, Casha S, Mackean G, Casselman L, Korngut L, Pringsheim T, Jette N.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S23-6. Review. No abstract available.

PMID:
23787262
39.

The case for neurological registry best practice guidelines in Canada.

Jette N, Johnston M, Pringsheim T, Korngut L.

Can J Neurol Sci. 2013 Jul;40(4 Suppl 2):S1-3. Review. No abstract available.

PMID:
23787261
40.

The CNDR: collaborating to translate new therapies for Canadians.

Korngut L, Campbell C, Johnston M, Benstead T, Genge A, Mackenzie A, McCormick A, Biggar D, Bourque P, Briemberg H, O'Connell C, Dojeiji S, Dooley J, Grant I, Hogan G, Johnston W, Kalra S, Katzberg HD, Mah JK, McAdam L, McMillan HJ, Melanson M, Selby K, Shoesmith C, Smith G, Venance SL, Wee J; CNDR Investigator Network.

Can J Neurol Sci. 2013 Sep;40(5):698-704.

PMID:
23968944
41.

A real-world glimpse into the epidemiology of ALS in Canada.

Dupré N, Korngut L.

Can J Neurol Sci. 2013 Sep;40(5):625. No abstract available.

PMID:
23968932
42.

The TREAT-NMD Duchenne muscular dystrophy registries: conception, design, and utilization by industry and academia.

Bladen CL, Rafferty K, Straub V, Monges S, Moresco A, Dawkins H, Roy A, Chamova T, Guergueltcheva V, Korngut L, Campbell C, Dai Y, Barišić N, Kos T, Brabec P, Rahbek J, Lahdetie J, Tuffery-Giraud S, Claustres M, Leturcq F, Ben Yaou R, Walter MC, Schreiber O, Karcagi V, Herczegfalvi A, Viswanathan V, Bayat F, de la Caridad Guerrero Sarmiento I, Ambrosini A, Ceradini F, Kimura E, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Oliveira J, Santos R, Neagu E, Butoianu N, Artemieva S, Rasic VM, Posada M, Palau F, Lindvall B, Bloetzer C, Karaduman A, Topaloğlu H, Inal S, Oflazer P, Stringer A, Shatillo AV, Martin AS, Peay H, Flanigan KM, Salgado D, von Rekowski B, Lynn S, Heslop E, Gainotti S, Taruscio D, Kirschner J, Verschuuren J, Bushby K, Béroud C, Lochmüller H.

Hum Mutat. 2013 Nov;34(11):1449-57. doi: 10.1002/humu.22390. Epub 2013 Aug 26.

PMID:
23913485
43.

Amyloid myoneuropathy mimicking inclusion body myositis.

Abuzinadah AR, Joseph JT, Korngut L.

Can J Neurol Sci. 2013 Mar;40(2):255-8. No abstract available.

PMID:
23419579
44.

Familial amyotrophic lateral sclerosis in Alberta, Canada.

Pfister T, Sekhon R, White M, Scott P, Munro S, Johnston M, Kalra S, Korngut L.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):273-7. doi: 10.3109/21678421.2012.754044. Epub 2013 Jan 4.

PMID:
23286750
45.

Establishing a Canadian registry of patients with amyotrophic lateral sclerosis.

Korngut L, Genge A, Johnston M, Benstead T, Bourque P, Briemberg H, Casey A, D'Amour M, Dupré N, Figlewicz D, Hader W, Johnston W, Kalra S, Melanson M, O'Connell C, Rouleau G, Shoesmith C, Wee J, Zinman L.

Can J Neurol Sci. 2013 Jan;40(1):29-35.

PMID:
23250124
46.

An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.

Toth C, Mawani S, Brady S, Chan C, Liu C, Mehina E, Garven A, Bestard J, Korngut L.

Pain. 2012 Oct;153(10):2073-82. doi: 10.1016/j.pain.2012.06.024. Epub 2012 Aug 23.

PMID:
22921260
47.

Overexpression of human HSP27 protects sensory neurons from diabetes.

Korngut L, Ma CH, Martinez JA, Toth CC, Guo GF, Singh V, Woolf CJ, Zochodne DW.

Neurobiol Dis. 2012 Sep;47(3):436-43. doi: 10.1016/j.nbd.2012.04.017. Epub 2012 May 5.

48.

The impact of enrollment in a specialized interdisciplinary neuropathic pain clinic.

Garven A, Brady S, Wood S, Hatfield M, Bestard J, Korngut L, Toth C.

Pain Res Manag. 2011 May-Jun;16(3):159-68.

49.

Calnexin deficiency leads to dysmyelination.

Kraus A, Groenendyk J, Bedard K, Baldwin TA, Krause KH, Dubois-Dauphin M, Dyck J, Rosenbaum EE, Korngut L, Colley NJ, Gosgnach S, Zochodne D, Todd K, Agellon LB, Michalak M.

J Biol Chem. 2010 Jun 11;285(24):18928-38. doi: 10.1074/jbc.M110.107201. Epub 2010 Apr 16.

50.

Phenotype of combined Duchenne and facioscapulohumeral muscular dystrophy.

Korngut L, Siu VM, Venance SL, Levin S, Ray P, Lemmers RJ, Keith J, Campbell C.

Neuromuscul Disord. 2008 Jul;18(7):579-82. doi: 10.1016/j.nmd.2008.03.011. Epub 2008 Jun 30.

PMID:
18586493

Supplemental Content

Loading ...
Support Center